Unsuspected pyocyanin effect in yeast under anaerobiosis

MicrobiologyOpen

Volumn 3, Issue 1, 2014, Pages 1-14

  Barakat, Rana ^a   Goubet, Isabelle ^a   Manon, Stephen ^b   Berges, Thierry ^c   Rosenfeld, Eric ^a  

^a UNIVERSITÉ DE LA ROCHELLE   (France)

^b Institut de Biochimie et Genetique Cellulaires   (France)

^c UNIVERSITÉ DE POITIERS   (France)

Author keywords

Aerobiosis; Anaerobiosis; Oxidative stress; Phenazine; Pyocyanin; Saccharomyces cerevisiae; Yeast mutants.

Indexed keywords

AEROBIOSIS; ANAEROBIOSIS; OXIDATIVE STRESS; PHENAZINE; PYOCYANIN; SACCHAROMYCES CEREVISIAE; YEAST MUTANTS.;

1,2-DIHYDROXYBENZENE-3,5-DISULFONIC ACID DISODIUM SALT; ACETYLCYSTEINE; ANAEROBIOSIS; ANTIOXIDANTS; ASCORBIC ACID; CANDIDA ALBICANS; DNA, FUNGAL; DRUG RESISTANCE, MULTIPLE, FUNGAL; FERMENTATION; INTERCALATING AGENTS; MITOCHONDRIA; OXIDATIVE STRESS; PYOCYANINE; SACCHAROMYCES CEREVISIAE; STILBENES;

EID: 84893803213     PISSN: None     EISSN: 20458827     Source Type: Journal    
DOI: 10.1002/mbo3.142     Document Type: Article

References (58)

1. Angell, S., B. J. Bench, H. Williams, and C. M. Watanabe 2006. Pyocyanin isolated from a marine microbial population: synergistic production between two distinct bacterial species and mode of action. Chem. Biol. 13:1349-1359.
2. Armstrong, A. V., and D. E. Stewart-Tull 1971. The site of the activity of extracellular products of Pseudomonas aeruginosa in the electron-transport chain in mammalian cell respiration. J. Med. Microbiol. 4:263-270.
3. Avéret, N., V. Fitton, O. Bunoust, M. Rigoulet, and B. Guérin 1998. Yeast mitochondrial metabolism: from in vitro to in situ quantitative study. Mol. Cell. Biochem. 184:67-79.
4. Baron, S., and J. Rowe 1981. Antibiotic action of pyocyanin. Antimicrob. Agents Chemother. 20:814-820.
5. Baron, S., G. Terranova, and J. Rowe 1989. Molecular mechanism of the antimicrobial action of pyocyanin. Curr. Microbiol. 18:223-230.
6. Beauvoit, B., M. Rigoulet, O. Bunoust, G. Raffard, P. Canioni, and B. Guérin 1993. Interactions between glucose metabolism and oxidative phosphorylations on respiratory-competent Saccharomyces cerevisiae cells. Eur. J. Biochem. 214:163-172.
7. Britigan, B. E., T. L. Roeder, G. T. Rasmussen, D. M. Shasby, M. L. McCormick, and C. Cox 1992. Interaction of the Pseudomonas aeruginosa secretory products pyocyanin and pyochelin generates hydroxyl radical and causes synergistic damage to endothelial cells. J. Clin. Invest. 90:2187-2196.
8. Caldwell, C. C., Y. Chen, H. S. Goetzmann, Y. Hao, M. T. Borchers, D. J. Hasset, et al. 2009. Pseudomonas aeruginosa exotoxin pyocyanin causes cystic fibrosis airway pathogenesis. Am. J. Pathol. 175:2473-2488.
9. Das, T., S. K. Kutty, N. Kumar, and M. Manefield 2013. Pyocyanin facilitates extracellular DNA binding to Pseudomonas aeruginosa influencing cell surface properties and aggregation. PLoS One 8:e58299. doi: 10.1371/journal.pone.0058299.
10. David, G., and P. J. Thornalley 1983. Free radical production from the aerobic oxidation of reduced pyridine nucleotides catalyzed by phenazine derivatives. Biochim. Biophys. Acta 724:456-464.
11. Dawes, I. W., and I. D. Hardie 1974. Selective killing of vegetative cells in sporulated yeast cultures by exposure to diethyl ether. Mol. Genet. Genomics 131:281-289.
12. Decottignies, A., B. Rogers, M. Kolaczkowski, E. Carvajal, E.Balzi, G. Conseil, et al. 2002. The pleiotropic drug ABC transporters from Saccharomyces cerevisiae (Chapter 11, Pp. 157-176). P. 301 in I. T. Paulsen and K. Lewis, eds. Microbial multidrug efflux. Horizon Scientific Press, Wymondham, U.K.
13. Dufour, V., J. Li, A. Flint, E. Rosenfeld, K. Rivoal, S.Georgeault, et al. 2013. Inactivation of the LysR regulator Cj1000 of Campylobacter jejuni affects host colonisation and respiration. Microbiology 159:1165-1178.
14. Friedheim, E. A. 1931. Pyocyanin, an accessory respiratory enzyme. J. Exp. Med. 54:207-221.
15. Friedheim, E. A. 1934. The effect of pyocyanin on the respiration of some normal tissues and tumours. Biochem. J. 28:173-179.
16. Gaisne, M., A. M. Bécam, J. Verdière, and C. J. Herbert 1999. A 'natural' mutation in Saccharomyces cerevisiae strains derived from S288c affects the complex regulatory gene HAP1 (CYP1). Curr. Genet. 36:195-200.
17. Gancedo, C., and R. Serrano 1989. Energy-yielding metabolism. 2nd ed. Vol. 3. Pp. 205-259 in J. S. Harisson and A. H. Rose, eds. The yeasts. Academic Press, NewYork.
18. Gloyne, L., G. D. Grant, A. V. Perkins, C. M. Mc Dermott, P. V. Jonhson, and G. J. Anderson 2011. Pyocyanin-induced toxicity in A549 respiratory cells is causally linked to oxidative stress. Toxicol. In Vitro 25:1353-1358.
19. Gu, M., and J. A. Imlay 2011. The SoxRS response of Escherichia coli is directly activated by redox-cycling drugs rather than by superoxide. Mol. Microbiol. 79:1136-1150.
20. Hassan, H. M., and I. Fridovitch 1980. Mechanism of the antibiotic action of pyocyanin. J. Bacteriol. 141:156-163.
21. Hassett, D. J., J. Cuppolettib, B. Trapnellc, S. V. Lymard, J. J. Rowee, S. S. Yoona, et al. 2002. Anaerobic metabolism and quorum sensing by Pseudomonas aeruginosa biofilms in chronically infected cystic fibrosis airways: rethinking antibiotic treatment strategies and drug targets. Adv. Drug Deliv. Rev. 54:1425-1443.
22. Hassett, D. J., M. D. Sutton, M. J. Schurr, A. B. Herr, C. C.Caldwell, and J. O. Matu 2009. Pseudomonas aeruginosa hypoxic or anaerobic biofilm infections within cystic fibrosis airways. Trends Microbiol. 17:130-138.
23. Hollstein, U., and R. J. Van Gemert 1971. Interaction of phenazines with polydeoxyribonucleotides. Biochemistry 10:497-504.
24. Hunter, R. C., V. Klepac-Ceraj, M. M. Lorenzi, H. Grotzinger, T. R. Martin, and D. K. Newman 2012. Phenazine content in the cystic fibrosis respiratory tract negatively correlates with lung function and microbial complexity. Am. J. Respir. Cell Mol. Biol. 47:738-745.
25. Hutter, E., H. Unterluggauer, A. Garedew, P. Jansen-Durr, and E. Gnaiger 2006. High resolution respirometry - a modern tool in aging research. Exp. Gerontol. 41:103-109.
26. Imlay, J. A. 2013. The molecular mechanisms and physiological consequences of oxidative stress: lessons from a model bacterium. Nat. Rev. Microbiol. 11:443-454.
27. Jacob, C., V. Jamier, and L. A. Ba 2011. Redox active secondary metabolites. Curr. Opin. Chem. Biol. 15:149-155.
28. Kerr, J. R., G. W. Taylor, A. Rutman, N. Høiby, P. J. Cole, and R. Wilson 1999. Pseudomonas aeruginosa pyocyanin and 1-hydroxyphenazine inhibit fungal growth. J. Clin. Pathol. 52:385-387.
29. Lau, G. W., H. Ran, F. Kong, D. J. Hassett, and D. Mavrodi 2004a. Pseudomonas aeruginosa pyocyanin is critical for lung infection in mice. Infect. Immun. 72:4275-4278.
30. Lau, G. W., D. J. Hassett, H. Ran, and F. Kong 2004b. The role of pyocyanin in Pseudomonas aeruginosa infection. Trends Mol. Med. 10:599-606.
31. Machan, Z. A., G. W. Taylor, T. L. Pitt, P. J. Cole, and R.Wilson 1992. 2-Heptyl-4-hydroxyquinoline N-oxide, an antistaphylococcal agent produced by Pseudomonas aeruginosa. J. Antimicrob. Chemother. 30:615-623.
32. McAlester, G., F. O'Gara, and J. P. Morrissey 2008. Signal-mediated interactions between Pseudomonas aeruginosa and Candida albicans. J. Med. Microbiol. 57:563-569.
33. Minard, K. I., and L. McAlister-Henn 2001. Antioxidant function of cytosolic sources of NADPH in yeast. Free Radic. Biol. Med. 31:832-843.
34. Muller, M. 2002. Pyocyanin induces oxidative stress in human endothelial cells and modulates the glutathione redox cycle. Free Radic. Biol. Med. 33:1527-1533.
35. Muller, M. 2006. Premature cellular senescence induced by pyocyanin, a redox-active Pseudomonas aeruginosa toxin. Free Radic. Biol. Med. 41:1670-1677.
36. Muller, M. 2009. Polyphenol cytotoxicity induced by the bacterial toxin pyocyanin: role of NQO1. Free Radic. Biol. Med. 47:84-91.
37. Muller, M. 2011. Glutathione modulates the toxicity of, but is not a biologically relevant reductant for, the Pseudomonas aeruginosa redox toxin pyocyanin. Free Radic. Biol. Med. 50:971-977.
38. Müller, P. K., K. Krohn, and P. Mühlradt 1989. Effects of pyocyanin, a phenazine dye from Pseudomonas aeruginosa, on oxidative burst and bacterial killing in human neutrophils. Infect. Immun. 57:2591-2596.
39. Okegbe, C., H. Sakhtah, M. D. Sekedat, A. Price-Whelan, and L. E. Dietrich 2012. Redox eustress: roles for redox-active metabolites in bacterial signaling and behavior. Antioxid. Redox Signal. 16:658-667.
40. O'Malley, Y. Q., K. J. Reszka, G. T. Rasmussen, M. Y. Abdalla, G. M. Denning, and B. E. Britigan 2003a. The Pseudomonas secretory product pyocyanin inhibits catalase activity in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 285:L1077-L1086.
41. O'Malley, Y. Q., M. Y. Abdalla, M. L. McCormick, K. J.Reszka, G. M. Denning, and B. E. Britigan 2003b. Subcellular localization of Pseudomonas pyocyanin cytotoxicity in human lung epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 284:L420-L430.
42. O'Malley, Y. Q., K. J. Reszka, D. R. Spitz, G. M. Denning, and B. E. Britigan 2004a. Pseudomonas aeruginosa pyocyanin directly oxidizes glutathione and decreases its levels in airway epithelial cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 287:L94-L103.
43. O'Malley, Y. Q., K. J. Reszka, and B. E. Britigan 2004b. Direct oxidation of 2′, 7′-dichlorodihydrofluorescein by pyocyanin and other redox-active compounds independent of reactive oxygen species production. Free Radic. Biol. Med. 36:90-100.
44. Price-Whelan, A., L. E. P. Dietrich, and D. K. Newman 2007. Pyocyanin alters redox homeostasis and carbon flux through central metabolic pathways in Pseudomonas aeruginosa PA14. J. Bacteriol. 189:6372-6381.
45. Rada, B., and T. L. Leto 2009. Redox warfare between airway epithelial cells and Pseudomonas: dual oxidase versus pyocyanin. Immunol. Res. 43:198-209.
46. Ran, H., D. J. Hassett, and G. W. Lau 2003. Human targets of Pseudomonas aeruginosa pyocyanin. Proc. Natl Acad. Sci. USA 100:14315-14320.
47. Rogers, B., A. Decottignies, M. Kolaczkowski, E. Carvajal, E.Balzi, and A. Goffeau 2001. The pleitropic drug ABC transporters from Saccharomyces cerevisiae. J. Mol. Microbiol. Biotechnol. 3:207-214.
48. Rosa, E. A., R. N. Rached, S. A. Ignácio, R. T. Rosa, W. José da Silva, J. Y. Yau, et al. 2008. Phenotypic evaluation of the effect of anaerobiosis on some virulence attributes of Candida albicans. J. Med. Microbiol. 57:1277-1281.
49. Rosenfeld, E., and B. Beauvoit 2003. Role of the non-respiratory pathways in the utilization of molecular oxygen by Saccharomyces cerevisiae. Yeast 20:1115-1144.
50. Sabra, W., E. J. Ki, and A.-P. Zeng 2002. Physiological responses of Pseudomonas aeruginosa PAO1 to oxidative stress in controlled microaerobic and aerobic cultures. Microbiology 148:3195-3202.
51. Slonimski, P. P., G. Perrodin, and J. H. Croft 1968. Ethidium bromide induced mutation of yeast mitochondria: complete transformation of cells into respiratory-deficient non-chromosomal 'petites'. Biochem. Biophys. Res. Commun. 30:232-239.
52. Stutts, M. J., M. R. Knowles, J. T. Gatzy, and R. C. Boucher 1986. Oxygen consumption and ouabain binding sites in cystic fibrosis nasal epithelium. Pediatr. Res. 20:1316-1320.
53. Wang, Y., S. Kern, and D. K. Newman 2010. Endogenous phenazine antibiotics promote anaerobic survival of Pseudomonas aeruginosa via extracellular electron transfer. J. Bacteriol. 192:365-369.
54. Williams, H. D., J. E. Zlosnik, and B. Ryall 2007. Oxygen, cyanide and energy generation in the cystic fibrosis pathogen Pseudomonas aeruginosa. Adv. Microb. Physiol. 52:1-71.
55. Wilson, R., D. A. Sykes, D. Watson, A. Rutman, G. W. Taylor, and P. J. Cole 1988. Measurement of Pseudomonas aeruginosa phenazine pigments in sputum and assessment of their contribution to sputum sol toxicity for respiratory epithelium. Infect. Immun. 56:2515-2517.
56. Worlitzsch, D., R. Tarran, M. Ulrich, U. Schwab, A. Cekici, K. C. Meyer, et al. 2002. Effects of reduced mucus oxygen concentration in airway Pseudomonas infections of cystic fibrosis patients. J. Clin. Invest. 109:317-325.
57. Yoon, S., R. Coakley, G. W. Lau, S. V. Lymar, B. Gaston, A. C. Karabulut, et al. 2006. Anaerobic killing of mucoid Pseudomonas aeruginosa by acidified nitrite derivatives under cystic fibrosis airway conditions. J. Clin. Invest. 116:436-446.
58. Yoon, S. S., R. F. Henningan, G. M. Hilliard, U. A. Ochsner, K. Parvatiyar, M. C. Kamani, et al. 2002. Pseudomonas aeruginosa anaerobic respiration in biofilms: relationship to cystic fibrosis pathogenesis. Dev. Cell 3:593-603.